weakly significantP= 0.06
l time - only 6% of patients with grade 3 and 4 were alive at 100 weeks following diagnosis compared to 89% of patients with grade 1 and 2 tumours. Sex of the astrocytoma patients, radiotherapy, chemotherapy or surgery did not significantly affect their survival (Table III), though surgery was weakly significant (P= 0.06).